Restaging breast cancer after somatostatin receptor scintigraphy with [In-111-DTPA-Phe-1]-octreotide

被引：0
|
作者：
Giannakenas, C
Tzorakoleftherakis, E
Kalofonos, HP
Petsas, T
Vassilakos, PJ
机构：
[1] UNIV PATRAS,REG HOSP,DEPT NUCL MED,PATRAS,GREECE
[2] UNIV PATRAS,REG HOSP,DEPT SURG,PATRAS,GREECE
[3] UNIV PATRAS,REG HOSP,DEPT ONCOL,PATRAS,GREECE
[4] UNIV PATRAS,REG HOSP,DEPT RADIOL,PATRAS,GREECE
来源：
EUROPEAN JOURNAL OF CANCER | 1997年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：219 / 219
页数：1
相关论文
共 50 条
  • [21] SOMATOSTATIN RECEPTOR IMAGING OF SMALL-CELL LUNG-CANCER (SCLC) BY MEANS OF IN-111-DTPA OCTREOTIDE SCINTIGRAPHY
    BOMBARDIERI, E
    CRIPPA, F
    CATALDO, I
    CHITI, A
    SEREGNI, E
    SORESI, E
    BOFFI, R
    INVERNIZZI, G
    BURAGGI, GL
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (02) : 184 - 188
  • [22] Physiological Uptake in the Pancreatic Head on Somatostatin Receptor Scintigraphy Using [111In-DTPA]Octreotide Incidence and Mechanism
    Brabander, Tessa
    Teunissen, Jaap
    Kwekkeboom, Dik
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (01) : 15 - 19
  • [23] Expression of somatostatin receptor in cervical carcinoma by 111In-DTPA-octreotide.
    Liu, RS
    Tsai, LC
    Lee, TW
    Yuan, CC
    Ng, HT
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 364P - 364P
  • [24] Radiation doses deriving from patients undergoing 111In-DTPA-d-Phe-1-octreotide scintigraphy
    Amir Kurtaran
    Josef Pfreitfellner
    Peter Schaffarich
    Peter Smith-Jones
    Bruno Niederle
    Markus Raderer
    Irene Virgolini
    Helmar Bergmann
    Ernst Havlik
    European Journal of Nuclear Medicine, 1997, 24 : 1298 - 1300
  • [25] SOMATOSTATIN RECEPTORS IN MENINGIOMAS - A SCINTIGRAPHIC STUDY USING IN-111 DTPA-D-PHE-1-OCTREOTIDE
    MAINI, CL
    TOFANI, A
    SCIUTO, R
    CARAPELLA, C
    CIOFFI, R
    CRECCO, M
    NUCLEAR MEDICINE COMMUNICATIONS, 1993, 14 (07) : 550 - 558
  • [26] Biodistribution of a new chelated somatostatin analogue, [In-111-DOTA-D-Phe-1-Tyr-3]-octreotide; Comparison with [In-111-DTPA-D-Phe-1]-octreotide in humans.
    Krenning, EP
    Bakker, WH
    Kwekkeboom, DJ
    Kooi, PPM
    vanderPluijm, ME
    Behe, M
    Macke, H
    JOURNAL OF NUCLEAR MEDICINE, 1997, 38 (05) : 382 - 382
  • [27] Radiation doses deriving from patients undergoing 111In-DTPA-D-Phe-1-octreotide scintigraphy
    Cormack, J
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1998, 25 (04): : 442 - 442
  • [28] Radiation doses deriving from patients undergoing In-111-DTPA-D-Phe-1-octreotide scintigraphy
    Kurtaran, A
    Pfreitfellner, J
    Schaffarich, P
    SmithJones, P
    Niederle, B
    Raderer, M
    Virgolini, I
    Bergmann, H
    Havlik, E
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1997, 24 (10) : 1298 - 1300
  • [29] In vivo detection of malignant thymic masses by indium-111-DTPA-D-Phe1-octreotide scintigraphy
    Lastoria, S
    Vergara, E
    Palmieri, G
    Acampa, W
    Varrella, P
    Caracò, C
    Bianco, RA
    Muto, P
    Salvatore, M
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (04) : 634 - 639
  • [30] SOMATOSTATIN RECEPTOR EXPRESSION IN THE THYROID DEMONSTRATED WITH IN-111-OCTREOTIDE SCINTIGRAPHY
    BECKER, W
    SCHRELL, U
    BUCHFELDER, M
    HENSEN, J
    WENDLER, J
    GRAMATZKI, M
    WOLF, F
    NUKLEARMEDIZIN, 1995, 34 (03) : 100 - 103
12345